Quattrone, Diego
 Distribuzione geografica
Continente #
NA - Nord America 2.789
EU - Europa 1.245
AS - Asia 557
SA - Sud America 101
AF - Africa 34
OC - Oceania 6
Continente sconosciuto - Info sul continente non disponibili 3
Totale 4.735
Nazione #
US - Stati Uniti d'America 2.766
IT - Italia 671
SG - Singapore 288
DE - Germania 139
CN - Cina 135
GB - Regno Unito 95
BR - Brasile 88
FI - Finlandia 54
FR - Francia 41
IE - Irlanda 38
AT - Austria 29
NL - Olanda 27
RO - Romania 26
SE - Svezia 26
RU - Federazione Russa 24
TR - Turchia 22
IN - India 20
CI - Costa d'Avorio 19
ES - Italia 19
HK - Hong Kong 18
KR - Corea 15
CA - Canada 12
TW - Taiwan 11
BE - Belgio 9
UA - Ucraina 9
GR - Grecia 8
IR - Iran 8
CH - Svizzera 7
EG - Egitto 7
MY - Malesia 7
MX - Messico 6
PK - Pakistan 6
AU - Australia 5
JP - Giappone 4
LT - Lituania 4
PL - Polonia 4
AL - Albania 3
AR - Argentina 3
BG - Bulgaria 3
EU - Europa 3
JM - Giamaica 3
KE - Kenya 3
MA - Marocco 3
PH - Filippine 3
SA - Arabia Saudita 3
VE - Venezuela 3
CZ - Repubblica Ceca 2
ID - Indonesia 2
KG - Kirghizistan 2
KZ - Kazakistan 2
PE - Perù 2
PT - Portogallo 2
UZ - Uzbekistan 2
ZA - Sudafrica 2
AE - Emirati Arabi Uniti 1
BD - Bangladesh 1
BH - Bahrain 1
BO - Bolivia 1
CL - Cile 1
CO - Colombia 1
DK - Danimarca 1
HR - Croazia 1
HU - Ungheria 1
IL - Israele 1
IQ - Iraq 1
KH - Cambogia 1
LV - Lettonia 1
MM - Myanmar 1
MO - Macao, regione amministrativa speciale della Cina 1
NO - Norvegia 1
NP - Nepal 1
NZ - Nuova Zelanda 1
PA - Panama 1
PY - Paraguay 1
SV - El Salvador 1
UY - Uruguay 1
Totale 4.735
Città #
Fairfield 453
Ashburn 342
Chandler 225
Woodbridge 195
Singapore 192
Palermo 190
Houston 179
Wilmington 156
Seattle 152
Ann Arbor 126
Cambridge 124
Medford 73
Boardman 51
Des Moines 47
Altamura 45
Lappeenranta 44
Rome 43
Princeton 42
Lawrence 39
Dublin 36
San Diego 35
Santa Clara 27
Ludwigshafen am Rhein 26
Nuremberg 24
Milan 22
London 21
Abidjan 19
Beijing 17
Redwood City 15
Alimena 14
New York 14
Seoul 14
Dearborn 13
Falls Church 13
San Paolo di Civitate 13
Council Bluffs 12
Florence 12
Nanjing 12
Tower Hamlets 11
Central 10
Vienna 10
Washington 10
Columbus 9
Helsinki 9
Brussels 8
Istanbul 8
Kumar 8
Los Angeles 8
Naples 8
Phoenix 8
São Paulo 8
Turin 8
Alcalá de Henares 7
Amsterdam 7
Bologna 7
Saint Petersburg 7
Tainan City 7
Hong Kong 6
Munich 6
Pescara 6
Wandsworth 6
Bergamo 5
Carini 5
Catania 5
Falkenstein 5
Guangzhou 5
Hangzhou 5
Messina 5
Padova 5
Paris 5
Rio de Janeiro 5
Shenyang 5
Agrigento 4
Dallas 4
Girona 4
Groningen 4
Karachi 4
Kilburn 4
Lakewood 4
Nanchang 4
Shanghai 4
Taipei 4
Taizhou 4
Tulsa 4
Bath 3
Belo Horizonte 3
Brooklyn 3
Capaci 3
Changsha 3
Esslingen am Neckar 3
Fremont 3
Jiaxing 3
Jinan 3
Kingston 3
Latina 3
Pune 3
Rovigo 3
Salvador 3
Soverato Marina 3
São Gonçalo 3
Totale 3.410
Nome #
Treated incidence of psychotic disorders in the multinational EU-GEI study 229
Transdiagnostic dimensions of psychopathology at first episode psychosis: findings from the multinational EU GEI study 202
Jumping to conclusions, general intelligence, and psychosis liability: findings from the multi-centre EU-GEI case-control study 176
The contribution of cannabis use to variation in the incidence of psychotic disorder across Europe (EU-GEI): a multicentre case-control study 175
Premorbid Adjustment and IQ in Patients With First-Episode Psychosis: A Multisite Case-Control Study of Their Relationship With Cannabis Use 159
Daily use of high-potency cannabis is associated with more positive symptoms in first-episode psychosis patients: The EU-GEI case-control study 154
IQ differences between patients with first episode psychosis in London and Palermo reflect differences in patterns of cannabis use. 145
The Relationship Between Polygenic Risk Scores and Cognition in Schizophrenia 142
DOES POLYGENIC RISK SCORE FOR SCHIZOPHRENIA IMPACT ON JUMPING TO CONCLUSIONS? PRELIMINARY FINDINGS FROM THE EU-GEI CASE-CONTROL STUDY 141
Risk factors for internet gaming disorder in a sample of 5,979 italian online gamers. 141
Prevalence and Risk Factors for Internet Gaming Disorder (IGD) in a sample of 5,979 Italian Online Gamers 140
BIOLOGICAL AND EPIDEMIOLOGICAL EXAMINATION OF TRANSDIAGNOSTIC AND SPECIFIC SYMPTOM DIMENSIONS AT PSYCHOSIS ONSET: FINDINGS FROM THE EUGEI STUDY 136
The influence of risk factors on the onset and outcome of psychosis: What we learned from the GAP study 130
F115POLYGENIC RISK SCORES FOR SCHIZOPHRENIA, BIPOLAR, AND MAJOR DEPRESSIVE DISORDERS PREDICT TRANSDIAGNOSTIC SYMPTOM DIMENSIONS AT FIRST EPISODE PSYCHOSIS 127
FIRST EPISODE PSYCHOTIC PATIENTS WITH A HISTORY OF FREQUENT CANNABIS USE EXPRESS MORE POSITIVE SYMPTOMS AT ILLNESS ONSET THAN THOSE WHO NEVER USED CANNABIS 126
Are Polygenic Risk Scores for Major Mental Disorders Associated with General or Specific Psychosis Symptom dimensions? 120
The EUropean Network of National Schizophrenia Networks Studying Gene–Environment Interactions (EU-GEI): Incidence and First-Episode Case–Control Programme 120
The Relationship Between Dissociative Experiences and Cannabis Use: a Systematic Review 117
Association of extent of cannabis use and psychotic like intoxication experiences in a multi-national sample of first episode psychosis patients and controls 117
DOES CANNABIS USE WORSEN PSYCHOTIC SYMPTOM PRESENTATION? 107
O4.8. CAN YOU SPOT EMOTIONS? FACIAL EMOTION RECOGNITION AND GENETIC RISK FOR PSYCHOSIS 104
Social disadvantage, linguistic distance, ethnic minority status and first-episode psychosis: Results from the EU-GEI case-control study 102
What does augment the risk to use cannabis on an everyday-basis in psychotic patients? 94
FIRST EPISODE PSYCHOSIS PATIENTS WHO USED CANNABIS DEVELOP THEIR ILLNESS AT A SIGNIFICANTLY YOUNGER AGE THAN THOSE WHO NEVER USED CONSISTENTLY ACROSS EUROPE AND BRAZIL 90
Cognitive functioning throughout adulthood and illness stages in individuals with psychotic disorders and their unaffected siblings 90
O3.1. ASSOCIATION OF EXTENT OF CANNABIS USE AND ACUTE INTOXICATION EXPERIENCES IN A MULTI-NATIONAL SAMPLE OF FIRST EPISODE PSYCHOSIS PATIENTS AND CONTROLS 86
Differences between female and male gamers and gender-specific risk-factors for internet gaming disorder (IGD) 84
JUMPING TO CONCLUSIONS AND FACIAL EMOTION RECOGNITION IMPAIRMENT IN FIRST EPISODE PSYCHOSIS ACROSS EUROPE 83
IS THE ERA OF CANDIDATE GENES X CANNABIS USE REALLY DEAD? 79
T42. JUMPING TO CONCLUSIONS IS ASSOCIATED WITH THE POLYGENIC RISK SCORE FOR INTELLIGENCE BUT NOT FOR SCHIZOPHRENIA. PRELIMINARY FINDINGS FROM THE EU-GEI STUDY 77
Facial Emotion Recognition in Psychosis and Associations With Polygenic Risk for Schizophrenia: Findings From the Multi-Center EU-GEI Case-Control Study 72
SOME OF THE INDIVIDUAL DIFFERENCES IN RISK TO DEVELOP PSYCHOSIS AMONG CANNABIS USERS CAN BE EXPLAINED BY WHERE THEY LIVE AND BY THEIR AGE AT FIRST USE 66
Psychological distress and suicidal ideation in Sicilian Medical Students: The SMS-ME project 65
COGNITION, METACOGNITION AND SOCIAL COGNITION AFTER A FIRST EPISODE PSYCHOSIS. PRELIMINARY RESULTS FROM A 5-YEAR-FOLLOW-UP STUDY 63
Migration history and risk of psychosis: Results from the multinational EU-GEI study 62
FIRST EPISODE PSYCHOSIS PATIENTS ACROSS EUROPE DIFFER IN INTELLECTUAL QUOTIENT (IQ) AND EXPOSURE TO ENVIRONMENTAL HAZARDS 61
Pre-training inter-rater reliability of clinical instruments in an international psychosis research project 59
EXPLORING SPECIFIC EFFECTS OF TYPE AND TIMING OF EXPOSURE TO CHILDHOOD ADVERSITY AND SYMPTOM DOMAINS IN FIRST EPISODE OF PSYCHOSIS: PRELIMINARY RESULTS FROM THE EUGEI PROJECT 51
ENVIRONMENTAL RISK FACTORS DIFFERENCES AMONG DIAGNOSTIC CATEGORIES IN EU-GEI STUDY 50
P.0170 Distinct polygenic risk scores in clusters of psychotic subjects with different premorbid trajectories and current IQ 49
Childhood Maltreatment, Educational Attainment, and IQ: Findings From a Multicentric Case-control Study of First-episode Psychosis (EU-GEI) 47
The relationship between genetic liability, childhood maltreatment, and IQ: findings from the EU-GEI multicentric case-control study 44
Perceived major experiences of discrimination, ethnic group, and risk of psychosis in a six-country case-control study 44
First-Episode Psychosis Patients Who Deteriorated in the Premorbid Period Do Not Have Higher Polygenic Risk Scores Than Others: A Cluster Analysis of EU-GEI Data 42
Use of multiple polygenic risk scores for distinguishing schizophrenia-spectrum disorder and affective psychosis categories in a first-episode sample; the EU-GEI study 40
Mapping genomic loci implicates genes and synaptic biology in schizophrenia 39
P.0171 The independent and joint effect of the endocannabinoid system and daily cannabis use on the risk of psychosis 39
F68. PREMORBID IQ, EDUCATIONAL LEVEL AND JUMPING TO CONCLUSIONS AS PREDICTORS OF CLINICAL OUTCOME AT FIRST ONSET OF PSYCHOSIS OVER THE NEXT 4 YEARS: THE GAP STUDY 34
Child maltreatment, migration and risk of first-episode psychosis: results from the multinational EU-GEI study 26
Beyond the Gender Binarism: Neural Correlates of Trans Men in a Functional Connectivity–Resting-State fMRI Pilot Study 26
Tobacco use in first-episode psychosis, a multinational EU-GEI study 25
The Kraepelian concept of schizophrenia: Dying but not yet dead 25
Cannabis use as a potential mediator between childhood adversity and first-episode psychosis: results from the EU-GEI case-control study 23
Jumping to conclusions at first onset of psychosis predicts longer admissions, more compulsory admissions and police involvement over the next 4 years: the GAP study 23
Genetics for mental health clinicians: a call for a globally accessible and equitable psychiatric genetics education 23
Duration of Untreated Psychosis in First-Episode Psychosis is not Associated with Common Genetic Variants for Major Psychiatric Conditions: Results from the Multi-Center EU-GEI Study 23
Transdiagnostic dimensions of symptoms and experiences associated with immune proteins in the continuity of psychosis 21
35.4 A PUBLIC HEALTH APPROACH TO THE PREVENTION OF PSYCHOSIS 21
Differences in Patterns of Stimulant Use and Their Impact on First-Episode Psychosis Incidence: An Analysis of the EUGEI Study 20
Traditional marijuana, high-potency cannabis and synthetic cannabinoids: increasing risk for psychosis 20
Antipsychotic dose mediates the association between polypharmacy and corrected QT interval 20
The increased incidence of psychosis during the COVID-19 pandemic in South London: The role of heavy cannabis use 20
Letter to the editor: Is polygenic risk for Parkinson's disease associated with less risk of first episode psychosis? 19
Neurobiological and Anti-Inflammatory Effects of a Deep Diaphragmatic Breathing Technique Based on Neofunctional Psychotherapy: A Pilot RCT 19
Differential gene expression analysis in blood of first episode psychosis patients 19
Abnormal illness behavior and Internet addiction severity: The role of disease conviction, irritability, and alexithymia 18
The Role of Social Deprivation and Cannabis Use in Explaining Variation in the Incidence of Psychotic Disorders: Findings From the EU-GEI Study 18
A prediction modelling and pattern detection approach for the first-episode psychosis associated to cannabis use 18
Duration of untreated disorder and cannabis use: An observational study on a cohort of young italian patients experiencing psychotic experiences and dissociative symptoms 18
Do Idiopathic Parkinson's Disease and Schizophrenia Lie on the Same Genetic Spectrum? 18
Does personality matter? Temperament and character dimensions in panic subtypes 17
Novel psychoactive substances and induced phenomena in psychopathology: The lysergic psychoma 17
Novel psychoactive substances in young adults with and without psychiatric comorbidities 17
Prevalence and correlates of QTc prolongation in Italian psychiatric care: Cross-sectional multicentre study 17
The effect of the COVID-19 pandemic on the treated incidence of psychotic disorders in South London 16
58.1 Cannabis use Across Europe: A Ticket to Psychosis? 16
BEHAVIOURAL PREDICTORS OF WEIGHT LOSS MAINTENANCE AFTER BARIATRIC SURGERY: A SCOPING REVIEW 15
Cannabis Use Cessation and the Risk of Psychotic Disorders: A Case–Control Analysis from the First Episode Case–Control EU-GEI WP2 Study 15
Genetic and psychosocial stressors have independent effects on the level of subclinical psychosis: findings from the multinational EU-GEI study 15
First-generation antipsychotics and QTc: any role for mediating variables? 14
The contribution of cannabis use to the increased psychosis risk among minority ethnic groups in Europe 14
Cognitive presentation at psychosis onset through premorbid deterioration and exposure to environmental risk factors 13
Unraveling Exercise Addiction: The Role of Narcissism and Self-Esteem 13
Should psychiatrists be more cautious about the long-term prophylactic use of antipsychotics? 12
Effects of continuation, frequency, and type of cannabis use on relapse in the first 2 years after onset of psychosis: an observational study 12
Novel psychoactive substance consumption is more represented in bipolar disorder than in psychotic disorders: A multicenter-observational study 12
The RS685012 Polymorphism of ACCN2, the Human Ortholog of Murine Acid-Sensing Ion Channel (ASIC1) Gene, is Highly Represented in Patients with Panic Disorder 11
Substance-induced psychosis and schizophrenia: the interaction point 11
A proof-of-concept analysis of data from the first NHS clinic for young adults with comorbid cannabis use and psychotic disorders 11
Variation of subclinical psychosis across 16 sites in Europe and Brazil: findings from the multi-national EU-GEI study 11
The effect of polygenic risk score and childhood adversity on transdiagnostic symptom dimensions at first-episode psychosis: evidence for an affective pathway to psychosis 8
Cannabis use and cognitive biases in people with first-episode psychosis and their siblings 8
The impact of schizophrenia genetic load and heavy cannabis use on the risk of psychotic disorder in the EU-GEI case-control and UK Biobank studies 7
Variation of subclinical psychosis as a function of population density across different European settings: Findings from the multi-national EU-GEI study 7
The association between reasons for first using cannabis, later pattern of use, and risk of first-episode psychosis: the EU-GEI case-control study 7
Methylomic signature of current cannabis use in two first-episode psychosis cohorts 6
Totale 5.505
Categoria #
all - tutte 26.895
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 26.895


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020276 0 0 0 0 0 0 0 0 0 72 106 98
2020/2021914 52 74 66 54 42 40 162 112 80 97 63 72
2021/2022703 46 90 26 34 34 67 27 100 56 61 61 101
2022/2023834 80 149 32 58 81 146 55 50 92 15 61 15
2023/2024769 14 50 17 79 46 57 87 33 1 53 38 294
2024/20251.176 164 80 80 156 79 73 155 147 169 73 0 0
Totale 5.505